Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Morgensztern

Showing results (81-90 of 184) with videos related to

Pageof 19
Sort By:
Translational Lung Cancer Research|December 3, 2015
Response to "Is post-operative radiotherapy of any benefit after R0 resection for N2 disease?"Cliff G Robinson, Aalok P Patel, Todd DeWees, et al.
Cancer Medicine|February 28, 2014
Risk-stratified patients with resectable soft tissue sarcoma benefit from epirubicin-based adjuvant chemotherapyAaron D Schenone, Jingqin Luo, Luke Montgomery, et al.
Chemotherapy|December 10, 2009
A phase I study of pegylated liposomal doxorubicin and irinotecan in patients with solid tumorsDaniel Morgensztern, Maria Q Baggstrom, Giancarlo Pillot, et al.
Lung Cancer (Amsterdam, Netherlands)|September 30, 2022
Ramucirumab plus atezolizumab in patients with stage IV non-small cell lung cancer previously treated with immune checkpoint inhibitorsBrett H Herzog, Saiama N Waqar, Siddhartha Devarakonda, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 8, 2018
Early Mortality in Patients Undergoing Adjuvant Chemotherapy for Non-Small Cell Lung CancerDaniel Morgensztern, Pamela S Samson, Saiama N Waqar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 30, 2006
Changing epidemiology of small-cell lung cancer in the United States over the last 30 years: analysis of the surveillance, epidemiologic, and end results databaseRamaswamy Govindan, Nathan Page, Daniel Morgensztern, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 15, 2010
Barriers to enrollment in non-small cell lung cancer therapeutic clinical trialsMaria Q Baggstrom, Saiama N Waqar, Ananth K Sezhiyan, et al.
Cancer|December 9, 2014
US breast cancer mortality trends in young women according to raceFoluso O Ademuyiwa, Feng Gao, Lin Hao, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 3, 2011
Thoroughness of mediastinal staging in stage IIIA non-small cell lung cancerMichael T Vest, Lynn Tanoue, Pamela R Soulos, et al.
Cardiovascular and Interventional Radiology|December 6, 2017
Percutaneous Image-Guided Ablation in the Treatment of Osseous Metastases from Non-small Cell Lung CancerYuntong Ma, Adam N Wallace, Saiama N Waqar, et al.
Pageof 19

Showing results (81-90 of 184) with videos related to

Sort By:
Pageof 19
Translational Lung Cancer Research|December 3, 2015
Response to "Is post-operative radiotherapy of any benefit after R0 resection for N2 disease?"Cliff G Robinson, Aalok P Patel, Todd DeWees, et al.
Cancer Medicine|February 28, 2014
Risk-stratified patients with resectable soft tissue sarcoma benefit from epirubicin-based adjuvant chemotherapyAaron D Schenone, Jingqin Luo, Luke Montgomery, et al.
Chemotherapy|December 10, 2009
A phase I study of pegylated liposomal doxorubicin and irinotecan in patients with solid tumorsDaniel Morgensztern, Maria Q Baggstrom, Giancarlo Pillot, et al.
Lung Cancer (Amsterdam, Netherlands)|September 30, 2022
Ramucirumab plus atezolizumab in patients with stage IV non-small cell lung cancer previously treated with immune checkpoint inhibitorsBrett H Herzog, Saiama N Waqar, Siddhartha Devarakonda, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 8, 2018
Early Mortality in Patients Undergoing Adjuvant Chemotherapy for Non-Small Cell Lung CancerDaniel Morgensztern, Pamela S Samson, Saiama N Waqar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 30, 2006
Changing epidemiology of small-cell lung cancer in the United States over the last 30 years: analysis of the surveillance, epidemiologic, and end results databaseRamaswamy Govindan, Nathan Page, Daniel Morgensztern, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 15, 2010
Barriers to enrollment in non-small cell lung cancer therapeutic clinical trialsMaria Q Baggstrom, Saiama N Waqar, Ananth K Sezhiyan, et al.
Cancer|December 9, 2014
US breast cancer mortality trends in young women according to raceFoluso O Ademuyiwa, Feng Gao, Lin Hao, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 3, 2011
Thoroughness of mediastinal staging in stage IIIA non-small cell lung cancerMichael T Vest, Lynn Tanoue, Pamela R Soulos, et al.
Cardiovascular and Interventional Radiology|December 6, 2017
Percutaneous Image-Guided Ablation in the Treatment of Osseous Metastases from Non-small Cell Lung CancerYuntong Ma, Adam N Wallace, Saiama N Waqar, et al.
Pageof 19